a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ICPUX | 6.28 | 0.10 | +1.62% |
Integrity Mid-North American Resources C | |||
AVFIX | 28.49 | 0.45 | +1.60% |
American Beacon Small Cp Val R5 | |||
VALSX | 40.51 | 0.40 | +1.00% |
Value Line Select Growth Fund | |||
AOFAX | 20.00 | N/A | N/A |
Alger Small Cap Focus A | |||
HLXCX | 11.05 | -0.03 | -0.27% |
Harding Loevner Emer Mkt ex Chn Instl |
A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with PGEN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then PGEN could also see price increases.
Ticker / NAME | Correlation To NKTX | 1D Price Change % | ||
---|---|---|---|---|
NKTX | 100% | +0.81% | ||
PGEN - NKTX | 49% Loosely correlated | +5.17% | ||
FATE - NKTX | 49% Loosely correlated | +1.83% | ||
BCRX - NKTX | 46% Loosely correlated | +1.25% | ||
ALLO - NKTX | 45% Loosely correlated | -3.30% | ||
CRBU - NKTX | 45% Loosely correlated | -1.51% | ||
More |